Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule

Ruha Shadaba Yale Institute for Global Health, New Haven, CT, USAView further author information

James V. Laveryb Hubert Department of Global Health, Rollins School of Public Health and Center for Ethics, Emory University, Atlanta, GA, USAView further author information

SarahAnn M. McFaddena Yale Institute for Global Health, New Haven, CT, USA;c Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, CT, USACorrespondence[email protected]

https://orcid.org/0000-0002-0511-5945 View further author information

Jad A. Elharakea Yale Institute for Global Health, New Haven, CT, USA;d Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USAView further author information

Fauzia Malika Yale Institute for Global Health, New Haven, CT, USA;d Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USAView further author information

Saad B. Omera Yale Institute for Global Health, New Haven, CT, USA;c Department of Internal Medicine, Infectious Disease, Yale School of Medicine, New Haven, CT, USA;e Yale School of Nursing, Orange, CT, USA;f Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USAView further author information

Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule

Table 1. Key ethical parameters

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule

Figures & data

Table 1. Key ethical parameters

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date